Bosulif 400 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQS1Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,904
Award facts
- Contract value 100% obligated
- $24,903.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,903.72 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Bosulif 400 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 7, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that serves as the primary mechanism for delivering pharmaceuticals and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor for the Defense Logistics Agency's medical supply chain operations. The company's extensive portfolio of federal contract awards encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Bosulif, a specialty oncology medication, is consistent with AmerisourceBergen's demonstrated capability to meet federal healthcare procurement requirements through open competition and reflects its role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting vehicles.
Quick answers
Who was awarded contract SPE2DR26FQS1Q?
SPE2DR26FQS1Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FQS1Q worth?
The government has obligated $24,904 on SPE2DR26FQS1Q.
Is contract SPE2DR26FQS1Q an order under another contract?
Yes. SPE2DR26FQS1Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS1Q competed?
The extent of competition for SPE2DR26FQS1Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award